Trial Investigating the Characteristics of Knismesis - a Lever to Explore Allodynia in Neuropathic Pain
NCT ID: NCT04621747
Last Updated: 2021-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
24 participants
INTERVENTIONAL
2021-11-23
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
healthy volunteers aged 18-35, balanced sex ratio, all of them undergoing the same battery of psychophysical explorations.
Battery of neurophysiological explorations
Visit 1: Biometry collection: gender, age, weight, height, eye colour.
* Questionnaires : the State and Trait Anxiety Inventory and the Pain Sensitivity
* Threshold of unpleasant light brightness, mechanical sensitivity threshold (von Frey hair).
* Training to estimate unpleasantness Under nociceptive and tickling stimuli, to use the handgrip.
* Mechanical pain threshold (electronic von Frey), heat pain threshold (Medoc Pathway).
* 48 stimulations applied to the back skin, following a predetermined plan with 12 different pathways, imbricated with 4 different speeds of movement.
Visit 2 (1 to 8 days later) :
* 42 stimulations applied to the back skin, to test the effect of stimulation intensity, the side of application, continuity break of the contact, and distraction by other cutaneous stimuli. The stimuli will follow the best paradigm as identified at the previous visit.
* 12 stimulations applied to forearm, cheeks, lower limbs, also testing the effect of hairiness.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Battery of neurophysiological explorations
Visit 1: Biometry collection: gender, age, weight, height, eye colour.
* Questionnaires : the State and Trait Anxiety Inventory and the Pain Sensitivity
* Threshold of unpleasant light brightness, mechanical sensitivity threshold (von Frey hair).
* Training to estimate unpleasantness Under nociceptive and tickling stimuli, to use the handgrip.
* Mechanical pain threshold (electronic von Frey), heat pain threshold (Medoc Pathway).
* 48 stimulations applied to the back skin, following a predetermined plan with 12 different pathways, imbricated with 4 different speeds of movement.
Visit 2 (1 to 8 days later) :
* 42 stimulations applied to the back skin, to test the effect of stimulation intensity, the side of application, continuity break of the contact, and distraction by other cutaneous stimuli. The stimuli will follow the best paradigm as identified at the previous visit.
* 12 stimulations applied to forearm, cheeks, lower limbs, also testing the effect of hairiness.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ยท BMI between 19 and 30 kg/m2 at inclusion.
Exclusion Criteria
* Natural intolerance to tickling.
* Any cutaneous, ocular or neurological disease contraindicating the psychophysical tests.
* Any disease or medical history that could expose the subject to unacceptable risk during the study.
* Any medication intake within 7 days before testing.
* History of drug or alcohol abuse.
* Involvement in another concomitant research protocol.
* Major dorsal hairiness.
* Inability to undergo the tests.
* Legal protection.
* Concomitant involvement in another clinical research.
* Refusal to participate.
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NEURO-DOL (UMR 1107 INSERM / UCA)
UNKNOWN
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital, Clermont Ferrand
Clermont-Ferrand, Auvergne, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
lise laclautre
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RBHP 2020 DUALE
Identifier Type: -
Identifier Source: org_study_id